Pharmacy Risk Management Wish-List: “Opt-In” Feature, “Core Protocols”
Executive Summary
Limited distribution programs for pharmaceuticals should include an "opt-in" feature to allow participation of any qualified pharmacy, the American Pharmaceutical Association told FDA during a May 22 hearing on risk management
You may also be interested in...
“Risk Management” May Be Too Risky For Pharmacy, NACDS Tells FDA
The participation of retail pharmacy in FDA-approved risk management programs may depend on "risk management" of a different kind: whether retailers feel sufficiently shielded from any added liability under novel regulatory schemes
“Risk Management” May Be Too Risky For Pharmacy, NACDS Tells FDA
The participation of retail pharmacy in FDA-approved risk management programs may depend on "risk management" of a different kind: whether retailers feel sufficiently shielded from any added liability under novel regulatory schemes
FDA Adverse Event Rating Scale Could Follow NCI Model, Consultant Says
The National Cancer Institute Common Toxicity Criteria could be a model for a standardized adverse event severity scale, International Pharmaceutical Consultants President Herbert Swarz, MD, suggested during a May 22 FDA hearing on risk management
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: